Fumagalli, C., Ioannou, A., Cappelli, F., Maurer, M. S., Razvi, Y., Porcari, A., Zampieri, M., Perfetto, F., Rauf, M. U., Martinez-Naharro, A., Venneri, L., Petrie, A., Whelan, C., Wechalekar, A., Lachmann, H., Hawkins, P. N., Olivotto, I., Marfella, R., Ungar, A., … Fontana, M. (2025). Clinical Phenotype and Prognostic Significance of Frailty in Transthyretin Cardiac Amyloidosis. JACC: CardioOncology, 7(3), 268–278. https://doi.org/10.1016/j.jaccao.2025.01.018

Masri, A., Bhattacharya, P., Medoff, B., Ejaz, A. U., Elman, M. R., Chandrashekar, P., Ives, L., Santos, A. M., Teruya, S. L., Zhao, Y., Huang, S., Wang, X., Sperry, B. W., Maurer, M. S., Soman, P., & Hanna, M. (2025). A Multicenter Study of Contemporary Long-Term Tafamidis Outcomes in Transthyretin Amyloid Cardiomyopathy. JACC: CardioOncology, 7(3), 282–293. https://doi.org/10.1016/j.jaccao.2024.12.005

Domingo-Relloso, A., Riffo-Campos, A. L., Zhao, N., Ayala, G., Haack, K., Manterola, C., Rhoades, D. A., Umans, J. G., Fallin, M. D., Herreros-Martinez, M., Pollan, M., Boerwinkle, E., Platz, E. A., Jones, M. R., Bressler, J., Joehanes, R., Ryan, C. P., Gonzalez, J. R., Levy, D., … Tellez-Plaza, M. (2024). Multicohort Epigenome-Wide Association Study of All-Cause Cardiovascular Disease and Cancer Incidence. JACC: CardioOncology, 6(5), 731–742. https://doi.org/10.1016/j.jaccao.2024.07.014

Huang, J., Lei, C., Hsi, D. H., Zheng, M., Ma, H., Ta, S., Hu, R., Han, C., Li, W., Li, J., Qu, D., Ruan, F., Wang, J., Wang, B., Zhao, X., Liu, J., Zhao, L., Wang, Z., Yang, J., & Liu, L. (2024). Echocardiography-Guided Radiofrequency Ablation for Cardiac Tumors. JACC: CardioOncology, 6(4), 560–571. https://doi.org/10.1016/j.jaccao.2024.03.008

Sánchez-Díaz, C. T., Babel, R. A., Iyer, H. S., Goldman, N., Zeinomar, N., Rundle, A. G., Omene, C. O., Pawlish, K. S., Ambrosone, C. B., Demissie, K., Hong, C.-C., Lovasi, G. S., Bandera, E. V., & Qin, B. (2024). Neighborhood Archetypes and Cardiovascular Health in Black Breast Cancer Survivors. JACC: CardioOncology, 6(3), 405–418. https://doi.org/10.1016/j.jaccao.2024.04.007

Lee, C., Drobni, Z. D., Zafar, A., Gongora, C. A., Zlotoff, D. A., Alvi, R. M., Taron, J., Rambarat, P. K., Schoenfeld, S., Mosarla, R. C., Raghu, V. K., Hartmann, S. E., Gilman, H. K., Murphy, S. P., Sullivan, R. J., Faje, A., Hoffmann, U., Zhang, L., Mayrhofer, T., … Neilan, T. G. (2022). Pre-Existing Autoimmune Disease Increases the Risk of Cardiovascular and Noncardiovascular Events After Immunotherapy. JACC: CardioOncology, 4(5), 660–669. https://doi.org/10.1016/j.jaccao.2022.11.008

Oren, D., DeFilippis, E. M., Lotan, D., Clerkin, K. J., Fried, J., Reshef, R., Fernandez, H., Lin, E., Amengual, J., Sayer, G., Uriel, N., & Raikhelkar, J. K. (2022). Successful CAR T Cell Therapy in a Heart and Kidney Transplant Recipient With Refractory PTLD. JACC: CardioOncology, 4(5), 713–716. https://doi.org/10.1016/j.jaccao.2022.09.002

Minnema, M. C., Dispenzieri, A., Merlini, G., Comenzo, R. L., Kastritis, E., Wechalekar, A. D., Grogan, M., Witteles, R., Ruberg, F. L., Maurer, M. S., Tran, N., Qin, X., Vasey, S. Y., Weiss, B. M., Vermeulen, J., & Jaccard, A. (2022). Outcomes by Cardiac Stage in Patients With Newly Diagnosed AL Amyloidosis. JACC: CardioOncology, 4(4), 474–487. https://doi.org/10.1016/j.jaccao.2022.08.011

Gonzalez-Lopez, E., Escobar-Lopez, L., Obici, L., Saturi, G., Bezard, M., Saith, S. E., AbouEzzeddine, O. F., Mussinelli, R., Gagliardi, C., Kharoubi, M., Griffin, J. M., Dispenzieri, A., Vilches, S., Perlini, S., Longhi, S., Oghina, S., Rivas, A., Grogan, M., Maurer, M. S., … Garcia-Pavia, P. (2022). Prognosis of Transthyretin Cardiac Amyloidosis Without Heart Failure Symptoms. JACC: CardioOncology, 4(4), 442–454. https://doi.org/10.1016/j.jaccao.2022.07.007

Griffin, J. M., Rosenthal, J. L., Grodin, J. L., Maurer, M. S., Grogan, M., & Cheng, R. K. (2021). ATTR Amyloidosis: Current and Emerging Management Strategies. JACC: CardioOncology, 3(4), 488–505. https://doi.org/10.1016/j.jaccao.2021.06.006

Hartnett, J., Jaber, W., Maurer, M., Sperry, B., Hanna, M., Collier, P., Patel, D. R., Wazni, O. M., & Donnellan, E. (2021). Electrophysiological Manifestations of Cardiac Amyloidosis. JACC: CardioOncology, 3(4), 506–515. https://doi.org/10.1016/j.jaccao.2021.07.010

Nativi-Nicolau, J., Siu, A., Dispenzieri, A., Maurer, M. S., Rapezzi, C., Kristen, A. V., Garcia-Pavia, P., LoRusso, S., Waddington-Cruz, M., Lairez, O., Witteles, R., Chapman, D., Amass, L., Grogan, M., Barroso, F. A., Van Cleemput, J., Fine, N., Schmidt, H., Gess, B., … Mueller, C. (2021). Temporal Trends of Wild-Type Transthyretin Amyloid Cardiomyopathy in the Transthyretin Amyloidosis Outcomes Survey. JACC: CardioOncology, 3(4), 537–546. https://doi.org/10.1016/j.jaccao.2021.08.009

Westin, O., Butt, J. H., Gustafsson, F., Schou, M., Salomo, M., Køber, L., Maurer, M., & Fosbøl, E. L. (2021). Two Decades of Cardiac Amyloidosis. JACC: CardioOncology, 3(4), 522–533. https://doi.org/10.1016/j.jaccao.2021.05.004

Kanelidis, A. J., Raikhelkar, J., Kim, G., Sayer, G., Bishop, M. R., Polonsky, T. S., & Uriel, N. (2020). CardioMEMS-Guided CAR T Cell Therapy for Lymphoma in a Patient With Anthracycline-Induced Cardiomyopathy. JACC: CardioOncology, 2(3), 515–518. https://doi.org/10.1016/j.jaccao.2020.06.005